FiveSix Pharma
Strategic consultancy and advisory services for the pharmaceutical, biotechnology, and related industries
Expertise
Integrated strategic planning
Program leadership and cross-functional collaboration
Program leadership and cross-functional collaboration
From pre-candidate to NDA/BLA filing - FiveSix Pharma excels at developing program strategy to align with product concepts, development of target product profiles for commercial and clinical differentiation, and advise on preclinical and clinical and integrated development strategies for effective decision making within the lifecycle of the program.
Program leadership and cross-functional collaboration
Program leadership and cross-functional collaboration
Program leadership and cross-functional collaboration
Global New Drug Development faces many challenges, particularly working within the context of multinational, matrixed/cross-functional program teams and organizations and in an industry in which technical, medical and scientific expertise may utilize combinations of both internal and external resources (such as CROs and other vendors)
Clinical trial planning, execution, and oversight
Program leadership and cross-functional collaboration
Clinical trial planning, execution, and oversight
FiveSix Pharma has 25+ years of experience in the planning, conduct, and execution of clinical studies in new drug development in numerous therapeutic areas (GI/GU, oncology, immunology, rare diseases, metabolic disorders, and neurological and psychiatric conditions) and partnered with most of the major CROs and many of the support vendors in the execution of clinical trials.
Data summarization, interpretation, and reporting
Data summarization, interpretation, and reporting
Clinical trial planning, execution, and oversight
Understanding and effectively communicating program or clinical trial results requires in-depth knowledge and expertise to asses the impact on the program and application of pre-defined Go/NoGo criteria. As programs progress through the phases of development, it is important to put new or emerging data into context of the clinical and commercial criteria in new drug development
Portfolio management and strategy
Data summarization, interpretation, and reporting
Other research and development services
Technical and scientific review and assessments for merger and acquisition, in-licensing, partnering, out-licensing, and advisement for due diligence and related activities requires extensive scientific, technical, and industry knowledge and experience. FiveSix Pharma provides services for technical and scientific evaluation, clinical development strategies, and insight to risk-based assessments.
Other research and development services
Data summarization, interpretation, and reporting
Other research and development services
If your program or company needs are not included or described within the primary capabilities of FiveSix Pharma - we welcome the opportunity to determine whether we can provide other solutions to specific problems or circumstances within your research and development programs, based on prior experience or referrals within FiveSix Pharma's professional network.